![]() |
Volumn 372, Issue 19, 2015, Pages 1853-1854
|
Revisiting the commercial-academic interface
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
EBOLA VACCINE;
NEOMYCIN;
STREPTOMYCIN;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG RESEARCH;
EBOLA HEMORRHAGIC FEVER;
EDITORIAL;
HUMAN;
MEDICAL LITERATURE;
MEDICAL SOCIETY;
ORGANIZATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TUBERCULOSIS;
UNITED KINGDOM;
CONFLICT OF INTEREST;
ETHICS;
FINANCIAL MANAGEMENT;
INTERPERSONAL COMMUNICATION;
PUBLIC RELATIONS;
PUBLICATION;
PUBLISHING;
UNIVERSITY HOSPITAL;
ACADEMIC MEDICAL CENTERS;
CONFLICT OF INTEREST;
DISCLOSURE;
DRUG INDUSTRY;
EDITORIAL POLICIES;
INTERPROFESSIONAL RELATIONS;
PERIODICALS AS TOPIC;
RESEARCH SUPPORT AS TOPIC;
|
EID: 84928978997
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMe1503623 Document Type: Editorial |
Times cited : (49)
|
References (5)
|